Catalyst Wire Dossier Catalyst Wire Dossier

CAMELLIA anti-CD47 antibody therapy

anti-CD47 antibody · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAMELLIA anti-CD47 antibody therapy, covering 2019-02-21 to 2019-02-21. Get the full timeline:

Most recent: Clinical Trial Update: CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies [Phase 1]

See pricing